Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
881.3 DKK | -0.79% | -1.41% | +26.24% |
07:00am | Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says | RE |
Mar. 28 | Novo Nordisk Asked by Bernie Sanders to Lower List Price of Diabetes, Weight-Loss Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.24% | 570B | |
+33.46% | 701B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B | |
-1.28% | 152B |
- Stock
- Equities
- Stock Novo Nordisk A/S - Nasdaq Copenhagen
- News Novo Nordisk A/S
- BNP Paribas Exane Upgrades Novo Nordisk to Neutral From Underperform